NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-244-2015-0-PCT-02 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use PCT PCT PCT/US2016/045289 Expired
NCI E-244-2015-0-CA-04 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CA National Stage 2994694 Pending
NCI E-249-2015-0-TW-03 Modified Yeast-Brachyury Immunotherapeutic Compositions. TW ORD 105124349 Pending
NCI E-231-2015-0-IN-06 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR PIT) OF SUPPRESSOR CELLS TO TREAT CANCER IN National Stage 201817003662 Issued
NCI E-231-2015-0-CA-03 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer CA National Stage 2994822 Issued
NCI E-231-2015-0-JP-07 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer JP National Stage 2018-506147 Issued
NIAID E-253-2011-3-US-09 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US DIV 15/226,744 9783595 Issued PDF
NCI E-231-2015-0-PCT-02 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer PCT PCT PCT/US2016/045090 Expired
NCI E-231-2015-0-CN-10 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer CN National Stage 201680058783.6 Abandoned
NCI E-231-2015-0-EP-05 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer EP National Stage 16748467.4 Pending
NCI E-175-2016-0-US-01 ANTI-KRAS-G12D T Cell Receptors US 62/369,883 Abandoned
NCI E-211-2016-0-US-01 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF US 62/369,861 Abandoned
NCI E-249-2015-0-CA-05 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CA National Stage 2994272 Issued
NCI E-249-2015-0-CN-06 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS CN National Stage 201680056316.X Issued
NCI E-249-2015-0-AU-04 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS AU National Stage 2016303525 Issued
NHLBI E-074-2014-2-US-02 System and Apparatus for Real-Time Processing Of Medical Imaging Raw Data Using Cloud Computing US National Stage 15/115,839 10068331 Issued PDF
NCI E-142-2014-0-PCT-02 Antigen-binding proteins targeting cd56 and uses thereof PCT PCT PCT/US2016/045027 Expired
NCI E-249-2015-0-PCT-02 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS PCT PCT PCT/US2016/044977 Expired
NCI E-142-2014-0-EP-05 Antigen-binding proteins targeting cd56 and uses thereof EP National Stage 16833684.0 Pending
NCI E-249-2015-0-KR-10 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS KR National Stage 10-2018-7006157 Pending
NCI E-142-2014-0-CA-04 Antigen-binding proteins targeting cd56 and uses thereof CA National Stage 2994412 Pending
NCI E-171-2018-7-CH-01 MODIFIED CELLS AND METHODS OF THERAPY CH EP 16833645.1 Issued
NCI E-171-2018-7-NL-01 MODIFIED CELLS AND METHODS OF THERAPY NL EP 16833645.1 Issued
NCI E-171-2018-7-DE-01 MODIFIED CELLS AND METHODS OF THERAPY DE EP 16833645.1 Issued
NCI E-171-2018-7-FR-01 MODIFIED CELLS AND METHODS OF THERAPY FR EP 16833645.1 Issued
NCI E-171-2018-7-EP-03 MODIFIED CELLS AND METHODS OF THERAPY EP National Stage 16833645.1 Issued
NCI E-171-2018-7-GB-01 MODIFIED CELLS AND METHODS OF THERAPY GB EP 16833645.1 Issued
NCI E-171-2018-7-JP-07 MODIFIED CELLS AND METHODS OF THERAPY JP National Stage 2018-525531 Issued
NCI E-171-2018-7-GB-06 MODIFIED CELLS AND METHODS OF THERAPY GB National Stage 1803280.5 Issued
NCI E-240-2015-1-CN-02 Methods of Analyzing Virus-Derived Therapeutics CN National Stage 201680045182.1 Issued
NCI E-240-2015-1-JP-04 Methods of Analyzing Virus-Derived Therapeutics JP National Stage 2018-525528 Issued
NCI E-240-2015-1-FR-07 Methods of Analyzing Virus-Derived Therapeutics FR EP 16750580.9 Issued
NCI E-240-2015-1-DE-06 Methods of Analyzing Virus-Derived Therapeutics DE EP 16750580.9 Issued
NCI E-240-2015-1-GB-08 Methods of Analyzing Virus-Derived Therapeutics GB EP 16750580.9 Issued
NCI E-240-2015-1-EP-03 Methods of Analyzing Virus-Derived Therapeutics EP National Stage 16750580.9 Issued
NCI E-171-2018-8-US-01 MODIFIED CELLS AND METHODS OF THERAPY US CIP 15/224,151 10166255 Abandoned PDF
NCI E-171-2018-7-PCT-01 MODIFIED CELLS AND METHODS OF THERAPY PCT PCT COMB PCT/US2016/044858 Expired
NCI E-171-2018-6-PCT-01 INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY PCT PCT COMB PCT/US2016/044856 Expired
NCI E-240-2015-1-PCT-01 Methods of Analyzing Virus-Derived Therapeutics PCT PCT COMB PCT/US2016/044788 Expired
NCI E-221-2015-0-PCT-02 ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS PCT PCT PCT/US2016/044777 Expired
NCI E-251-2015-0-PCT-02 Optical Trap for Rheological Characterization of Biological Materials PCT PCT PCT/US2016/044850 Expired
NCI E-171-2018-9-US-01 MODIFIED CELLS AND METHODS OF THERAPY US CIP 15/224,159 Abandoned
NCI E-171-2018-7-CN-05 MODIFIED CELLS AND METHODS OF THERAPY CN National Stage 201680059180.8 Pending
NCI E-171-2018-7-CA-02 MODIFIED CELLS AND METHODS OF THERAPY CA National Stage 2993431 Pending
CC E-096-2016-0-US-01 Powered Gait Assistance Systems US 62/368,926 Abandoned
NCI E-167-2010-0-EP-10 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling EP DIV 16181625.1 Abandoned
CC E-277-2015-0-US-01 TRANSPERINEAL ULTRASOUND-GUIDED PROSTATE BIOPSY US 62/367,923 Abandoned
NCI E-227-2014-0-US-08 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD US National Stage 15/114,505 10143721 Issued PDF
NCATS E-202-2016-1-US-01 COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US 62/366,855 Abandoned
NIDDK E-011-2014-0-CN-06 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer CN National Stage 201480074026.9 Abandoned